Category: Company News

Northwest Biotherapeutics (USOTC:NWBO) has entered into a collaboration with NHS Blood and Transplant to support manufacturing of its experimental DCVax-L cancer vaccine, strengthening UK production infrastructure while the treatment’s marketing authorisation application remains under regulatory review. Key Investor Takeaways Why NWBO Stock Is in Focus Northwest Biotherapeutics has announced a collaboration with NHS Blood and…

Veea Inc. (NASDAQ:VEEA) has restored full compliance with Nasdaq’s continued listing requirements following board restructuring and the earlier resolution of its minimum bid-price deficiency, removing previously disclosed regulatory concerns over its exchange listing. Key Investor Takeaways Why VEEA Stock Is in Focus Veea has confirmed that it now meets Nasdaq’s continued listing standards after completing…

Genentech, part of Roche Group (USOTC:RHHBY), has received FDA approval for Tecentriq in combination with chemotherapy for a specific form of stage III colon cancer, expanding the immunotherapy’s U.S. indications following positive Phase III clinical trial results. Key Investor Takeaways Why RHHBY Stock Is in Focus Genentech has secured U.S. Food and Drug Administration approval…

Vivakor (NASDAQ:VIVK) has signed a non-binding letter of intent to acquire Direct Midstream, outlining a stock-heavy transaction that could expand its Permian Basin infrastructure and oilfield waste management operations. Key Investor Takeaways Why VIVK Stock Is in Focus Vivakor has established the principal financial terms for its proposed acquisition of 100% of Direct Midstream, a…

OFA Group (NASDAQ:OFAL) has completed the acquisition and title registration of a coastal property in Choshi, Japan, adding a company-owned asset as it evaluates a potential senior living development and advances its broader regional real estate strategy. Key Investor Takeaways Why OFAL Stock Is in Focus OFA Group has confirmed that its wholly owned subsidiary,…

VCI Global (NASDAQ:VCIG) has confirmed that its US$125 million standby equity purchase facility provides optional access to capital over 36 months, rather than representing an immediate share issuance, while acknowledging the potential for future shareholder dilution. Key Investor Takeaways Why VCIG Stock Is in Focus VCI Global has issued a clarification regarding its recent Form…

NetClass Technology (NASDAQ:NTCL) has entered the AI companion smart hardware market through a new joint venture, introducing a consumer-focused product line as it seeks to diversify beyond its established education technology business. Key Investor Takeaways Why NTCL Stock Is in Focus NetClass Technology has officially launched its first interactive AI smart pet product, LinkeeBot, through…

The investment gives Buzbuzian Capital exposure to Getchell Gold’s Fondaway Canyon project, which has a preliminary economic assessment outlining a US$1 billion pre-tax net present value and projected annual gold production of 150,000 ounces. Key Investor Takeaways Why GGLDF Stock Is in Focus Getchell Gold has secured a $300,000 investment from Canadian family office Buzbuzian…

China SXT Pharmaceuticals has agreed to sell 8 million shares at $1.50 each, alongside warrants containing a zero-cash exercise provision and an additional $12 million purchase option for institutional investors. Key Investor Takeaways Why SXTC Stock Is in Focus China SXT Pharmaceuticals has entered into a definitive securities purchase agreement with institutional investors for a…

DarkIris has announced a $6 million financing to support working capital and corporate operations, with a warrant structure that could substantially increase its outstanding share count. Key Investor Takeaways Why DKI Stock Is in Focus DarkIris has priced a best-efforts public offering expected to generate approximately $6 million in gross proceeds before placement agent fees…